Plandai Biotech Stock Today

PLPL Stock  USD 0.0001  0.00  0.00%   

Performance

Solid

 
Weak
 
Strong

Odds Of Distress

Above Average

 
High
 
Low
Plandai Biotech is selling for 1.0E-4 as of the 19th of March 2025. This is a No Change since the beginning of the trading day. The stock's lowest day price was 1.0E-4. Plandai Biotech has over 59 % chance of experiencing financial distress in the next 2 years of operation, but had a somewhat solid returns during the last 90 days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 19th of March 2025. Click here to learn more.
Planda Biotechnology, Inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. Planda Biotechnology, Inc. is based in London, the United Kingdom. Diamond Ranch is traded on OTC Exchange in the United States. The company has 263.19 M outstanding shares. More on Plandai Biotech

Moving against Plandai Pink Sheet

  0.4SSNLF Samsung ElectronicsPairCorr
  0.31CIMO Chimera InvestmentPairCorr
  0.31CMSQF Computershare LimitedPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Plandai Pink Sheet Highlights

ChairmanRoger BaylisDuffield
Thematic Ideas
(View all Themes)
Business ConcentrationDisruptive Technologies, Marijuana, Health Care, Biotechnology, Shell Companies, Financial Services (View all Sectors)
Plandai Biotech [PLPL] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 276.35 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Plandai Biotech's market, we take the total number of its shares issued and multiply it by Plandai Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Plandai Biotech conducts business under Biotechnology sector and is part of Health Care industry. The entity has 263.19 M outstanding shares. Plandai Biotech currently holds about 7.96 K in cash with (1.1 M) of positive cash flow from operations.
Check Plandai Biotech Probability Of Bankruptcy

Plandai Biotech Risk Profiles

Plandai Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Plandai Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Financial Widgets Now

   

Financial Widgets

Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
All  Next Launch Module

Other Information on Investing in Plandai Pink Sheet

Plandai Biotech financial ratios help investors to determine whether Plandai Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Plandai with respect to the benefits of owning Plandai Biotech security.